デフォルト表紙
市場調査レポート
商品コード
1704654

体外転写テンプレートの世界市場レポート 2025年

In-Vitro Transcription Templates Global Market Report 2025


出版日
ページ情報
英文 200 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
体外転写テンプレートの世界市場レポート 2025年
出版日: 2025年04月01日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

体外転写テンプレート市場規模は、今後数年で飛躍的な成長が見込まれます。2029年にはCAGR23.4%で29億米ドルに成長します。予測期間の成長は、バイオテクノロジーの進歩、研究開発活動への注目の高まり、体外転写テンプレートの使用量の増加、病気の早期診断の需要、mRNAベースのワクチンのニーズの高まりに起因しています。予測期間における主な動向としては、RNA合成技術の開発、技術の進歩、バイオテクノロジーの進歩、酵素合成技術の進歩、自動化とデジタル化の統合などが挙げられます。

遺伝子治療の台頭が体外転写テンプレート市場の成長を牽引すると予想されます。遺伝子治療は、欠陥遺伝子を修正することによって病気を治療または予防するために、細胞遺伝子を修正することを含みます。CRISPRのような技術の進歩、多額の投資、最近の治療の成功がこのアプローチへの関心を高めています。体外転写テンプレートは、mRNAに基づく治療、siRNAに基づく治療、遺伝子編集技術に必要なRNA分子を提供し、遺伝性疾患や病気の治療を可能にすることで、遺伝子治療において重要な役割を果たしています。例えば、2024年3月現在、米国保健社会福祉省傘下の連邦機関である食品医薬品局(FDA)は、36の遺伝子治療を承認し、さらに500の遺伝子治療を準備中であると報告しています。FDAは、2025年までに毎年10~20件の遺伝子治療を承認すると見込んでおり、体外転写テンプレート市場の拡大を牽引する遺伝子治療への注目の高まりをさらに強調しています。

体外転写テンプレート市場の主要プレーヤーは、RNAベースの治療効率と効果を高め、生産コストを削減し、様々な治療用途で患者の転帰を改善するために、自己増幅型RNA合成サービスを積極的に開拓しています。この技術は、宿主細胞内での自己複製が可能なRNA生産を可能にし、最小限のRNAインプットから高度のタンパク質発現をもたらし、それによってRNAベースの治療効率と効果を向上させる。例えば、2024年5月、米国のバイオテクノロジー企業であるGenScript Biotech Corporationは、自己増幅RNA(saRNA)合成サービスを発表し、体外転写RNA合成サービスを拡大しました。この新サービスは、少量のRNAから強固なタンパク質発現を可能にすることで、ワクチン、免疫療法、遺伝子治療の効力と有効性を高める。saRNAプラットフォームは、投与量を減らし、製造コストを下げ、患者の転帰を向上させることを目的としており、高純度とタンパク質発現の向上を保証する広範な研究開発に支えられています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界体外転写テンプレート PESTEL分析(政治、社会、技術、環境、法的要因、促進要因と抑制要因)
  • 最終用途産業の分析
  • 世界の体外転写テンプレート市場:成長率分析
  • 世界の体外転写テンプレート市場の実績:規模と成長, 2019-2024
  • 世界の体外転写テンプレート市場の予測:規模と成長, 2024-2029, 2034F
  • 世界体外転写テンプレート総アドレス可能市場(TAM)

第6章 市場セグメンテーション

  • 世界の体外転写テンプレート市場治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ワクチン
  • 治療的
  • 世界の体外転写テンプレート市場調査段階別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 探索的
  • 臨床
  • 世界の体外転写テンプレート市場:疾患別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • がん
  • 感染症
  • 生活習慣病
  • 遺伝性疾患
  • その他の病気
  • 世界の体外転写テンプレート市場:エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 製薬およびバイオテクノロジー企業
  • 契約調査機関(CRO)と契約製造機関(CMO)
  • 学術と調査
  • その他のエンドユーザー
  • 世界の体外転写テンプレート市場、ワクチンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • mRNAワクチン
  • DNAワクチン
  • 世界の体外転写テンプレート市場、治療のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 遺伝子治療
  • RNAベースの治療薬

第7章 地域別・国別分析

  • 世界の体外転写テンプレート市場:地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の体外転写テンプレート市場:国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 体外転写テンプレート市場:競合情勢
  • 体外転写テンプレート市場:企業プロファイル
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • Eurofins Genomics LLC Overview, Products and Services, Strategy and Financial Analysis
    • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Illumina Inc.
  • Bio-Rad Laboratories Inc.
  • Qiagen N.V.
  • Integrated DNA Technologies Inc.
  • Promega Corporation
  • Genescript Biotech Corporation
  • Takara Bio Inc.
  • New England Biolabs
  • OriGene Technologies Inc.
  • Cayman Chemical
  • Synthego Corporation
  • Synbio Technologies
  • Creative Diagnostics
  • VectorBuilder Inc.
  • Bio-Synthesis Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 体外転写テンプレート市場2029:新たな機会を提供する国
  • 体外転写テンプレート市場2029:新たな機会を提供するセグメント
  • 体外転写テンプレート市場2029:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r30516

In-vitro transcription templates are specific DNA sequences crafted to guide RNA synthesis under controlled laboratory conditions. These templates feature designated promoter regions recognized by RNA polymerase, enabling the efficient production of RNA molecules for diverse applications such as research, diagnostic advancements, and therapeutic development. They serve as reliable and precise resources for RNA synthesis, supporting activities in molecular biology and genetic investigations.

The primary applications of in-vitro transcription templates are in vaccine development and therapeutic production. Integral multi-tandem valves represent a category of single-unit valves that consolidate multiple control functions into a compact body. These valves find utility across various research stages including exploratory and clinical phases in treating ailments such as cancer, infectious diseases, lifestyle disorders, genetic conditions, and other medical conditions. They are utilized by pharmaceutical and biotechnology firms, contract research organizations (CROs) and contract manufacturing organizations (CMOs), academic and research institutions, and other relevant entities.

The in-vitro transcription templates market research report is one of a series of new reports from The Business Research Company that provides in-vitro transcription templates market statistics, including the in-vitro transcription templates industry global market size, regional shares, competitors with in-vitro transcription templates market share, detailed in-vitro transcription templates market segments, market trends, and opportunities, and any further data you may need to thrive in the in-vitro transcription templates industry. These in-vitro transcription templates market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The in-vitro transcription templates market size has grown exponentially in recent years. It will grow from $1.01 billion in 2024 to $1.25 billion in 2025 at a compound annual growth rate (CAGR) of 23.7%. The growth in the historic period can be attributed to rise in cases of chronic diseases, increase in investments in R&D in healthcare and pharmaceutical sectors, improvements in gene therapy technology, collaborations and partnerships and developments in gene therapy.

The in-vitro transcription templates market size is expected to see exponential growth in the next few years. It will grow to $2.9 billion in 2029 at a compound annual growth rate (CAGR) of 23.4%. The growth in the forecast period can be attributed to Increase in advancement in biotechnology, rise in focus in R&D activities, rise in usage of in-vitro transcription templates, demand for early diagnosis of diseases and increasing need for mRNA-based vaccines. Major trends in the forecast period include developments in RNA synthesis technologies, technological advancements, advancement in biotechnology, advancements in enzymatic synthesis techniques, and integration of automation and digitalization.

The rise in gene therapy's prominence is anticipated to drive growth in the in-vitro transcription templates market. Gene therapy involves modifying cellular genes to treat or prevent illnesses by rectifying defective genes. Technological advancements such as CRISPR, substantial investments, and recent treatment successes have heightened interest in this approach. In-vitro transcription templates play a crucial role in gene therapy by providing the necessary RNA molecules for mRNA-based therapies, siRNA-based therapies, and gene editing technologies, enabling the treatment of genetic disorders and diseases. For instance, as of March 2024, the Food and Drug Administration (FDA), a US-based federal agency under the Department of Health and Human Services, reported approving 36 gene therapies, with another 500 in the pipeline. They expect to approve 10-20 annually by 2025, further emphasizing the growing focus on gene therapy driving the in-vitro transcription templates market's expansion.

Key players in the in-vitro transcription templates market are actively developing self-amplifying RNA synthesis services to enhance RNA-based therapy efficiency and effectiveness, reduce production costs, and improve patient outcomes across various therapeutic applications. This technology allows RNA production capable of self-replication within host cells, leading to heightened protein expression from minimal RNA input, thereby improving RNA-based therapy efficiency and effectiveness. For example, in May 2024, GenScript Biotech Corporation, a US-based biotechnology firm, unveiled a self-amplifying RNA (saRNA) synthesis service, expanding its in-vitro transcription RNA synthesis offerings. This new service boosts the potency and efficacy of vaccines, immunotherapies, and gene therapies by enabling robust protein expression from small RNA quantities. The saRNA platform aims to decrease dosages, lower production costs, and enhance patient outcomes, supported by extensive research and development ensuring high purity and improved protein expression.

In September 2022, Lonza, a Switzerland-based pharmaceutical and biotechnology company, partnered with Torchlight to incorporate Touchlight's innovative doggybone DNA (dbDNA) technology into its mRNA development and manufacturing services. This collaboration broadens Lonza's customer offerings, providing faster, scalable, and purer alternatives to traditional plasmid DNA (pDNA) methods, strengthening Lonza's integrated mRNA manufacturing capabilities. Torchlight, a UK-based biotechnology firm, specializes in DNA production and development through an enzymatic process.

Major companies operating in the in-vitro transcription templates market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Eurofins Genomics LLC, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Integrated DNA Technologies Inc., Promega Corporation, Genescript Biotech Corporation, Takara Bio Inc., New England Biolabs, OriGene Technologies Inc., Cayman Chemical, Synthego Corporation, Synbio Technologies, Creative Diagnostics, VectorBuilder Inc., Bio-Synthesis Inc., TriLink BioTechnologies, Norgen Biotek Corporation, Genaxxon BioScience GmbH, Enzo Life Sciences Inc., GeneCopoeia

North America was the largest region in the in-vitro transcription templates market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro transcription templates market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the in-vitro transcription templates market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The in-vitro transcription templates market consists of revenues earned by entities by providing services such as RNA synthesis, quality control services, scale-up production, and technical support. The market value includes the value of related goods sold by the service provider or included within the service offering. The in-vitro transcription templates market also includes sales of DNA plasmids, linearized DNA, and synthetic oligonucleotides. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In-Vitro Transcription Templates Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on in-vitro transcription templates market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in-vitro transcription templates ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The in-vitro transcription templates market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Treatment: Vaccine; Therapeutic
  • 2) By Research Stage: Exploratory; Clinical
  • 3) By Disease: Cancer; Infectious Disease; Lifestyle Disease; Genetic Disease; Other Diseases
  • 4) By End User: Pharmaceutical And Biotechnology Companies; Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs); Academics And Research; Other End Users
  • Subsegments:
  • 1) By Vaccine: MRNA Vaccines; DNA Vaccines
  • 2) By Therapeutic: Gene Therapy; RNA-Based Therapeutics
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; Eurofins Genomics LLC; Agilent Technologies Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. In-Vitro Transcription Templates Market Characteristics

3. In-Vitro Transcription Templates Market Trends And Strategies

4. In-Vitro Transcription Templates Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global In-Vitro Transcription Templates Growth Analysis And Strategic Analysis Framework

  • 5.1. Global In-Vitro Transcription Templates PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global In-Vitro Transcription Templates Market Growth Rate Analysis
  • 5.4. Global In-Vitro Transcription Templates Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global In-Vitro Transcription Templates Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global In-Vitro Transcription Templates Total Addressable Market (TAM)

6. In-Vitro Transcription Templates Market Segmentation

  • 6.1. Global In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Vaccine
  • Therapeutic
  • 6.2. Global In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Exploratory
  • Clinical
  • 6.3. Global In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer
  • Infectious Disease
  • Lifestyle Disease
  • Genetic Disease
  • Other Diseases
  • 6.4. Global In-Vitro Transcription Templates Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical And Biotechnology Companies
  • Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs)
  • Academics And Research
  • Other End Users
  • 6.5. Global In-Vitro Transcription Templates Market, Sub-Segmentation Of Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • MRNA Vaccines
  • DNA Vaccines
  • 6.6. Global In-Vitro Transcription Templates Market, Sub-Segmentation Of Therapeutic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gene Therapy
  • RNA-Based Therapeutics

7. In-Vitro Transcription Templates Market Regional And Country Analysis

  • 7.1. Global In-Vitro Transcription Templates Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global In-Vitro Transcription Templates Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific In-Vitro Transcription Templates Market

  • 8.1. Asia-Pacific In-Vitro Transcription Templates Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China In-Vitro Transcription Templates Market

  • 9.1. China In-Vitro Transcription Templates Market Overview
  • 9.2. China In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India In-Vitro Transcription Templates Market

  • 10.1. India In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan In-Vitro Transcription Templates Market

  • 11.1. Japan In-Vitro Transcription Templates Market Overview
  • 11.2. Japan In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia In-Vitro Transcription Templates Market

  • 12.1. Australia In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia In-Vitro Transcription Templates Market

  • 13.1. Indonesia In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea In-Vitro Transcription Templates Market

  • 14.1. South Korea In-Vitro Transcription Templates Market Overview
  • 14.2. South Korea In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe In-Vitro Transcription Templates Market

  • 15.1. Western Europe In-Vitro Transcription Templates Market Overview
  • 15.2. Western Europe In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK In-Vitro Transcription Templates Market

  • 16.1. UK In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany In-Vitro Transcription Templates Market

  • 17.1. Germany In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France In-Vitro Transcription Templates Market

  • 18.1. France In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy In-Vitro Transcription Templates Market

  • 19.1. Italy In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain In-Vitro Transcription Templates Market

  • 20.1. Spain In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe In-Vitro Transcription Templates Market

  • 21.1. Eastern Europe In-Vitro Transcription Templates Market Overview
  • 21.2. Eastern Europe In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia In-Vitro Transcription Templates Market

  • 22.1. Russia In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America In-Vitro Transcription Templates Market

  • 23.1. North America In-Vitro Transcription Templates Market Overview
  • 23.2. North America In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA In-Vitro Transcription Templates Market

  • 24.1. USA In-Vitro Transcription Templates Market Overview
  • 24.2. USA In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada In-Vitro Transcription Templates Market

  • 25.1. Canada In-Vitro Transcription Templates Market Overview
  • 25.2. Canada In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America In-Vitro Transcription Templates Market

  • 26.1. South America In-Vitro Transcription Templates Market Overview
  • 26.2. South America In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil In-Vitro Transcription Templates Market

  • 27.1. Brazil In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East In-Vitro Transcription Templates Market

  • 28.1. Middle East In-Vitro Transcription Templates Market Overview
  • 28.2. Middle East In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa In-Vitro Transcription Templates Market

  • 29.1. Africa In-Vitro Transcription Templates Market Overview
  • 29.2. Africa In-Vitro Transcription Templates Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa In-Vitro Transcription Templates Market, Segmentation By Research Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa In-Vitro Transcription Templates Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. In-Vitro Transcription Templates Market Competitive Landscape And Company Profiles

  • 30.1. In-Vitro Transcription Templates Market Competitive Landscape
  • 30.2. In-Vitro Transcription Templates Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Eurofins Genomics LLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. In-Vitro Transcription Templates Market Other Major And Innovative Companies

  • 31.1. Illumina Inc.
  • 31.2. Bio-Rad Laboratories Inc.
  • 31.3. Qiagen N.V.
  • 31.4. Integrated DNA Technologies Inc.
  • 31.5. Promega Corporation
  • 31.6. Genescript Biotech Corporation
  • 31.7. Takara Bio Inc.
  • 31.8. New England Biolabs
  • 31.9. OriGene Technologies Inc.
  • 31.10. Cayman Chemical
  • 31.11. Synthego Corporation
  • 31.12. Synbio Technologies
  • 31.13. Creative Diagnostics
  • 31.14. VectorBuilder Inc.
  • 31.15. Bio-Synthesis Inc.

32. Global In-Vitro Transcription Templates Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The In-Vitro Transcription Templates Market

34. Recent Developments In The In-Vitro Transcription Templates Market

35. In-Vitro Transcription Templates Market High Potential Countries, Segments and Strategies

  • 35.1 In-Vitro Transcription Templates Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 In-Vitro Transcription Templates Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 In-Vitro Transcription Templates Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer